Merk reported $2.3B in Selling and Administration Expenses for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Abbott ABT:US $ 2.79B 158M
Abbvie ABBV:US $ 3.06B 110M
Amgen AMGN:US $ 1.23B 197M
AstraZeneca AZN:LN 3.06B 1.03B
Astrazeneca AZN:US 3.06B 1.03B
Biogen BIIB:US $ 634.9M 153M
Bristol Myers Squibb BMY:US $ 1.83B 523M
Catalent CTLT:US $ 207M 21M
Coherus Biosciences CHRS:US $ 48.75M 1.3M
Eli Lilly And LLY:US $ 1.56B 34.1M
Endo International Ordinary Shares ENDP:US 226M 18.48M
Gilead Sciences GILD:US $ 1.08B 567M
GlaxoSmithKline GSK:LN 2.68B 227M
Glaxosmithkline GSK:US 2.68B 227M
Horizon Pharma HZNP:US 372.73M 26.22M
Intercept Pharmaceuticals ICPT:US $ 50.01M 10.58M
JAZZ PHA JAZZ:US 308.81M 53.95M
Johnson & Johnson JNJ:US $ 5.94B 1.22B
Medtronic MDT:US 2.53B 4M
Merk MRK:US $ 2.3B 518M
Novartis NOVN:VX 3.5B 486M
Novartis NVS:US 3.5B 486M
Pacira Pharmaceuticals PCRX:US $ 64.26M 13.06M
Perrigo Ordinary Shares PRGO:US 282.3M 13M
Phibro Animal Health PAHC:US $ 52.43M 4.05M
Prestige Brands PBH:US $ 64.74M 1.48M
Regeneron Pharmaceuticals REGN:US $ 450M 109.6M
Revance Therapeutics RVNC:US $ 43.97M 588K
Teva Pharmaceutical Industries TEVA:US 819M 39M
United Therapeutics UTHR:US $ 79M 47.9M
Zoetis ZTS:US $ 465M 128M